Oramed Pharmaceuticals
ORMP
#9128
Rank
HK$1.28 B
Marketcap
HK$31.52
Share price
0.00%
Change (1 day)
88.52%
Change (1 year)

EPS for Oramed Pharmaceuticals (ORMP)

EPS in 2026 (TTM): HK$17.43

According to Oramed Pharmaceuticals's latest financial reports the company's current EPS (TTM) is HK$17.48. In 2025 the company made an earnings per share (EPS) of HK$12.00 an increase over its 2024 EPS that were of -HK$3.76.

EPS history for Oramed Pharmaceuticals from 2005 to 2026

Annual EPS

Year EPS Change
2026 (TTM)HK$17.4345.29%
2025HK$12.00-418.75%
2024-HK$3.76-442.86%
2023HK$1.10-114.89%
2022-HK$7.3720.51%
2021-HK$6.1239.29%
2020-HK$4.39-31.71%
2019-HK$6.43-4.65%
2018-HK$6.748.86%
2017-HK$6.19-9.2%
2016-HK$6.8229.85%
2015-HK$5.258.06%
2014-HK$4.865.08%
2013-HK$4.633.51%
2012-HK$4.47137.5%
2011-HK$1.88-60%
2010-HK$4.70-0%
2009-HK$4.70-16.67%
2008-HK$5.65-25%
2007-HK$7.53700%
2006-HK$0.94303.56%
2005-HK$0.23

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novo Nordisk
NVO
HK$33.68 92.62%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
HK$20.07 14.78%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-HK$47.91-373.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-HK$0.55-103.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
HK$2.90-83.41%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel